Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory Response
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Flecainide is an antiarrhythmic agent that is used primarily in the treatment of cardiac arrhythmias. Some evidences also suggest that flecainide can participate in alveolar fluid clearance and inflammatory responses. This experiment was aimed to evaluate the effects of flecainide on sepsis induced acute lung injury in a rat model. Methods: Rats were treated with subcutaneous infusion of saline or flecainide (0.1 or 0.2 mg/kg/hr) by a mini-osmotic pump. Subcutaneous infusion was started 3 hours before and continued until 8 hours after intraperitoneal injection of saline or endotoxin. Animals were sacrificed for analyses of severity of acute lung injury with wet to dry (W/D) ratio and lung injury score (LIS) in lung and inflammatory responses with level of leukocyte, polymorphonuclear neutrophils (PMNs) and inteleukin-8 (IL-8) in bronchoalveolar lavages fluid (BALF). Results: Flecainide markedly improved dose dependently sepsis induced acute lung injury as analysed by W/D ratio (from 2.24 ± 0.11 to 1.76 ± 0.09, p < 0.05) and LIS (from 3 to 1, p < 0.05), and inflammatory response as determined by leukocyte (from 443 ± 127 to 229 ± 95, p < 0.05), PMNs (from 41.43 ± 17.63 to 2.43 ± 2.61, p < 0.05) and IL-8 (from 95.00 ± 15.28 to 40.00 ± 10.21, p < 0.05) in BALF. Conclusions: Flecanide improve sepsis induced acute lung injury in rats by controlling inflammatory responses.
Abstract
Background: Flecainide is an antiarrhythmic agent that is used primarily in the treatment of cardiac arrhythmias. Some evidences also suggest that flecainide can participate in alveolar fluid clearance and inflammatory responses. This experiment was aimed to evaluate the effects of flecainide on sepsis induced acute lung injury in a rat model. Methods: Rats were treated with subcutaneous infusion of saline or flecainide (0.1 or 0.2 mg/kg/hr) by a mini-osmotic pump. Subcutaneous infusion was started 3 hours before and continued until 8 hours after intraperitoneal injection of saline or endotoxin. Animals were sacrificed for analyses of severity of acute lung injury with wet to dry (W/D) ratio and lung injury score (LIS) in lung and inflammatory responses with level of leukocyte, polymorphonuclear neutrophils (PMNs) and inteleukin-8 (IL-8) in bronchoalveolar lavages fluid (BALF). Results: Flecainide markedly improved dose dependently sepsis induced acute lung injury as analysed by W/D ratio (from 2.24 ± 0.11 to 1.76 ± 0.09, p < 0.05) and LIS (from 3 to 1, p < 0.05), and inflammatory response as determined by leukocyte (from 443 ± 127 to 229 ± 95, p < 0.05), PMNs (from 41.43 ± 17.63 to 2.43 ± 2.61, p < 0.05) and IL-8 (from 95.00 ± 15.28 to 40.00 ± 10.21, p < 0.05) in BALF. Conclusions: Flecanide improve sepsis induced acute lung injury in rats by controlling inflammatory responses.
참고문헌 (28)
- Held HD, "Mechanisms of endotoxin-induced airway and pulmonary vascular hyperreactivity in mice", Am J Respir Crit Care Med, 162(4Pt 1), pp.1547~1552 (2000)
- Kosari F, "Subunit stoichiometry of the epithelial sodium channel", J Biol Chem, 273, pp.13469~13474 (1998)
- Samlowski WE, "Flecainideinduced immune neutropenia. Documentation of a hapten-mediated mechanism of cell destruction", Arch Intern Med, 147, pp.383~384 (1987)
- Kwak SH, "The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins", J Leukoc Biol, 78, pp.937~945 (2005)
- Abraham E, "HMG-1 as a mediator of acute lung inflammation", J Immunol, 165, pp.2950~2954 (2000)
- Rowe SJ, "Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury", J Immunol, 169, pp.6401~6407 (2002)
- Asti C, "Lipopolysaccharide-induced lung injury in mice. I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage", Pulm Pharmacol Ther, 13, pp.61~69 (2000)
- Szarka RJ, "A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation", J Immunol Methods, 202, pp.49~57 (1997)
- Kollef MH, "The acute respiratory distress syndrome", N Engl J Med, 332, pp.27~37 (1995)
- Saito T, "Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse", Cell Tissue Res, 321, pp.75~88 (2005)
- Guillot L, "Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4", J Biol Chem, 279, pp.2712~2718 (2004)
- Roos-Engstrand E, "Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure", Eur Respir J, 25, pp.797~803 (2005)
- Donnelly SC, "Interleukin-8 and development of adult respiratory distress syndrome in atrisk patient groups", Lancet, 341, pp.643~647 (1993)
- Reinhart K, "Markers for sepsis diagnosis: what is useful?", Crit Care Clin, 22, pp.503~519 (2006)
- O’Brodovich HM, "The role of active Na+ transport by lung epithelium in the clearance of airspace fluid", New Horiz, 3, pp.240~247 (1995)
- Baines DL, "Lipopolysaccharide modifies amiloride-sensitive Na+ transport processes across human airway cells: role of mitogen-activated protein kinases ERK 1", 2 and 5, 2010, pp.459, 451~463
- Wyncoll DL, "Acute respiratory distress syndrome", Lancet, 354, pp.497~501 (1999)
- Ware LB, "Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome", Am J Respir Crit Care Med, 163, pp.1376~1383 (2001)
- Sznajder JI, "Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive", Am J Respir Crit Care Med, 163, pp.1293~1294 (2001)
- Matthay MA, "Invited review:Active fluid clearance from the distal air spaces of the lung", J Appl Physiol, 93, pp.1533~1541 (2002)
- Egli M, "Defective respiratory amiloridesensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice", J Physiol, 560(3), pp.857~865 (2004)
- Abraham E, "Neutrophils as early immunologic effectors in hemorrhage-or endotoxemia-induced acute lung injury", Am J Physiol Lung Cell Mol Physiol, 279, pp.L1137~L1145 (2000)
- Yum HK, "Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury", J Immunol, 167, pp.6601~6608 (2001)
- Selvatici R, "Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils", Eur J Pharmacol, 534, pp.1~11 (2006)
- Geering K, "Functional roles of Na,K-ATPase subunits", Curr Opin Nephrol Hypertens, 17, pp.526~532 (2008)
- Dagenais A, "Downregulation of ENaC activity and expression by TNF-alpha in alveolar epithelial cells", Am J Physiol Lung Cell Mol Physiol, 286, pp.L301~L311 (2004)
- Ye X, "IL-1beta stimulates alveolar fluid absorption in fetal guinea pig lungs via the hypothalamuspituitary-adrenal gland axis", Am J Physiol Lung Cell Mol Physiol, 286, pp.L756~L766 (2004)
- de Seigneux S, "NF-kappaB inhibits sodium transport via down-regulation of SGK1 in renal collecting duct principal cells", J Biol Chem, 283, pp.25671~25681 (2008)